Warning letter
Oklahoma Blood Institute Institutional Review Board: warning letter of Jul 10, 2006
FDA warning letter UCM075976 · Center for Biologics Evaluation and Research
Key facts
| Reference number | UCM075976 |
|---|---|
| Company | Oklahoma Blood Institute Institutional Review Board |
| Subject | Institutional Review Board (IRB) |
| Issue date | Jul 10, 2006 |
| Posted date | Jul 10, 2006 |
| Issuing office | Center for Biologics Evaluation and Research |
| Product type | Devices |
| CFR sections cited | 56.115(a), 56, 56.110, 56.120, 56.107(e), 56.108(a), 56.115(a)(1), 56.120(a), 56.120(c), 56.108(c), 56.109(e) |
| Country | 3 |
| Inspection city | Oklahoma City |
| Inspection ZIP | 73104-3251 |
| Inspection start date | Feb 14, 2006 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: